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Objectives. T%
purpose of this study was to assess the effect of
different degivo of ischemia on circulating and cardiac neurohor-
inones and v e.
Background.
Neuroendecrine activation and subsequent sys-
temic vasoconstriction may complicate ischemia . Whether this
relates to severity of ischemia and subsequent cardiac dysfunction,
and whether neurohormonal balance in the ischemic area
changes, is unknown .
Methods. Fifty-six normotensive patients with coronary artery
disease were evaluated during incremental atrial pacing. On the
basis of ST segment changes, patients were classified in a nonisch-
emic (n = 11) or ischemic group (n = 45), the latter patients were
subsequently classified as lactate (n = 28) or nonlactate (n = 17)
producing, to identify neurohormonal changes in the effluent of
the ischemlc myocardium.
Results . Angina occurred in 55%, 82% and 82% of patients in
the nonischemic, lactate- and nonlactate-producing groups, re-
spectively . Baseline hemodynamic variables and nearohormones
were comparable in all groups, as were heart rate, rate-pressure
product and coronary hemodynamic variables during pacing . In
lactate producers, contractility did not improve, relaxation dete-
riorated, left ventricular tilling pressure increased and cardiac
Systemic neuroendocrine activation is a consistent observa-
tion in heart failure (1) and in its preceding stage, asymp-
tomatic left ventricular dysfunction (2). It is also well estab-
lished in the acute phase of myocardial infarction, where
circulating levels of catecholamines, renin-angiotensin and
arginine-vasopressin appear to be related to the degree of left
ventricular dysfunction (3-5) . Recent evidence suggests that
circulating catecholamines and renin-angiotensin levels also
become activated during short periods of pacing-induced
myocardial ischemia (6) . Of potential clinical importance,
ischemia-induced neurohormonal activation in humans is
accompanied by systemic vasoconstriction and an increase
in arterial pressures (6) . It is unknown, however, whether
From the Zuiderziekenhuis and Sticares Cardiovascular Research Foun-
dation, Rotterdam, The Netherlands.
Manuscript received March 24,1993
; revised manuscript received August
11, 1993, accepted August 13, 1993
.
Address for correspondence :
Dr . Willem J . Remme, Sticares Cardiovas-
cular Research Foundation, P.O. Box 52006, 3007 LA Rotterdam, The
Netherlands
.
©1994 by the American College of Cardiology
JACC Vol. 23, No. i
January 1994 :82-91
output decreased during pacing, indicating more severe ischemia
compared with that in nonlactate producers . Neurohormmtones did
not change in the nonischemic group . In contrast, arterial and
coronary venous catecholamines increased significantly more in
lactate producers than lea nonlactate producers (arterial Porepi-
nephrine by 68% vs . 36%, respectively). Moreover, arterial
angiotensin II increased in lactate producers from a baseline mean
d_ SEM of 6.8 ¢ 0.9 to 9 .7 d: 1 .6 pntollliter (p < 0.05),
accompanied by a sustained 23% increase in systemic resistance
and arterial pressures . In lactate producers, baseline net cardiac
norepinephrine release changed to net uptake during pacing
(-0.05 ± 0.02 vs. 0.06 ± 0.05 nmol/min, p < 0.05) . Epinept-ine
uptake increased in all patients with ischemia, albeit more in
lactate producers.
Conclusions. Circulating catecholamines and renin-angiotensin
levels are activated, and systemic vasotone is increased in relation
to the degree of ischemia . Cardiac epinephrine uptake increases,
whereas net baseline norepinephrine release from the ischemic
myocardium changes to net uptake. Modulation of this neurohor .
monal activation may provide an alternative mode to limit inch .
emia.
(J Am Coll Cardiol 1994,2.3 :82-91)
this neurohormonal stimulation relates to the severity of
ischemia and could result from ischemia-induced cardiac
dysfunction .
In animal models of ischemia, cardiac norepinephrine
efflux increases, indicative of enhanced cardiac sympathetic
stimulation (7), but only when ischemia is severe and sus-
tained. Whether, in humans temporary episodes of mild to
moderate ischemia, such as occur during exercise- or pacing-
induced stress, also result in enhanced cardiac sympathetic
stimulation and norepinephrine release, is unclear (8-10).
Neither is the effect of myocardial ischemia on cardiac
angiotensin fluxes known .
In the present study, sequential changes in systemic and
transcardiac catecholamines and angiotensin II levels were
investigated during pacing-induced myocardial ischernia in
normotensive patients with coronary artery disease without
heart failure and were related to the severity of ischemia and
subsequent cardiac dysfunction . Second, an attempt was
made to study cardiac n afroho.atonal release in the effluent
from ischemic myocardium .
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Methods 0 mm Hg total pressure]) and relaxation indexes (peak
negative dP/di, isovolumetric relaxation indexes tau, and
taU2) , mean and phasic arterial pressures, right anki pres-
sure, cardiac output and coronary sinus blood flow . All
fluid-filled catheters were calibrated, using Bentley transduc-
ers, with a zero reference level set at midehest. The micro-
manometer pressure was balanced to zero and superimposed
on the conventional pressure tracings . After appropriate
calibration, all pressures, coronary flow, cardiac output and
dP/dt were recorded on paper, using a COR 1000 catheter-
ization laboratory system. They were also determined on-line
by a Mennen catheterization laboratory computer system .
Through this system, pressures and pressure-derived contrac-
tility indexes were calculated in 15 to 20 consecutive beats to
average out respiratory variations . Contractility indexes and
peak negative dP/dt were calculated and displayed on-line . In
contrast, tau, and tau t were measured off-fine (11) . Coronary
sinus blood flow was determined by the thermodilution tech-
nique, as previously described (12) . The Mennen catheteriza-
tion laboratory system displays 1-s measurements of mean
coronary How, which allows instantaneous estimation of the
stability of coronary flow recordings .
At the end of the study, the pressure curves from the
femoral artery were compared with a simultaneous recording
from the aortic root by the micromanometer catheter to
compensate for any difference between proximal and distal
arterial pressures . Heart rate and ST segment changes were
determined from 100-mm/s recordings of electrocardio-
graphic (ECG) leads I, It and V_5 . The ST segment was
measured in 3 to 5 consecutive beats 80 ms after the J point,
using a calibrated magnifying glass .
Blood sample collection and assay of metabolites . Simul-
taneous blood samples from the left ventricle and coronary
sinus were used to determine lactate levels and oxygen
saturation values on an OSM-80 oximeter (Waters Associa-
tion). 'The sampling procedure and analysis of lactate have
been published in detail elsewhere (13)_ The standard devi-
ation in our laboratory is 0 .012 mmoYliter .
Neurohumorat measurements . Neurohormones were as-
sessed in a minimum of 6 ml of blood simultaneously
collected from the left ventricle and coronary sinus in
precooled syringes. For the assay of angiotensin 11, 3 ml was
immediately transferred to ice-cold tubes containing 4 mg of
ethylenediaminetetraacetic acid and 0.06 mg of o-phenan-
throline . The remaining 3 ml was transferred to ice-cold
tubes containing 500 liters/U of heparin and 3 mg/ml of
glutathione for determination of norepinephrine, epinephrine
and dopamine . Samples were centrifuged at 3,000g under
cooled conditions and the supernatants frozen at -50°C .
Catecholamines were determined by radioenzymatic assay
and high pressure liquid chromatography to separate the
radioactive products (14), whereas angiotensin 11 was as-
sessed by radioimmunoassay (15) .
Calculations . From the measured hemodynamic vari-
ables, the following variables were derived using standard
formulas (16) :
coronary vascular resistance (mm Hg/nil per
Patients After approval by the institutional Ethical Re-
view Committee and informed consent was obtained, 56
patients (4 women, 52 men ; mean age 54 years [range 31 to
73]) were studied . Subjects were referred for coronary
angiography for the evaluation of stable angina pectoris with
documented exercise-induced ischemia or a previous myo-
cardial infarction, or both, or anginalike chest pain without
signs of myocardial ischemia . To be included, patients had to
be normotensive without symptoms of heart failure, valvular
disease or conduction disturbances . Previous myocardial
infarctions had to be at least I month old . Patients with
unstable angina were not included .
All cardiac therapy was withheld 36 to 72 h before study,
depending on plasma half-lives . Only short-eating nitroglyc-
erin was allowed up to 6 h before study . Oral anticoagulant
agents and antiplatelet therapy (e .g ., aspirin) were withheld 2
to 3 days and 10 days before the investigation, respectively .
Fifty-two patients had significant coronary artery disease,
defined as >70% diameter narrowing of at least one epicar-
dial coronary artery . Objective signs of ischemia during
prestudy exercise testing were present in 32 patients and
documented previous myocardial infarctions in 24 . In the
latter group, nine patients had no demonstrable signs of
ischemia during exercise .
Catheterization procedures . All patients were studied in
the fasting state at the same time in the morning, without
premeditation . Before the study, coronary angiography was
performed with the Seldinger technique . Thereafter, a 7F
Millar or 8F Sentron pigtail microtip manometer catheter
was advanced to the left ventricle through an 8F or 9F
arterial Desilet introducer system in the right femoral artery
to record left ventricular pressures . The side arm of the,
introducer system was used to monitor arterial pressure . A
7F balloon-tipped triple-lumen thermodilution catheter (Ed-
wards Laboratory) was positioned in a pulmonary artery
through an 8F Desilet introducer system in the right femoral
vein. A 7F coronary sinus thermodilution and pacing cathe-
ter (Wilton Webster Laboratories model CCS-7U-90B) was
introduced through a right brachial vein in the coronary
sinus. The position of this catheter was such that the
proximal thermistor was at least 3 cmm beyond the orifice of
the coronary sinus, its position stable, enabling a rapid
sequence of blood sampling . Absence of atrial reflux into the
coronary sinus under the study conditions was confirmed by
a bolus injection of 10 ml of saline solution into the right
atrium. After instrumentation, the position of the catheters
was recorded on videodisc to allow rechecking of their
respective positions during the study .
Hemodynamic and electrocardiographic measurements .
The hemodynamic variables in this study included left ven-
tricular peak systolic, mean and end-diastolic pressures ; left
ventricular pressure-derived contractility (first derivative of
left ventricular pressure [dP/dt], peak positive dP/dt, at
40 mm Hg and
Vma,.
[dP/dt/pressure (P) extrapolated to P =
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min), systemic vascular resistance (dynes scan--5),
stroke in-
dex (ml/beat per m 2), stroke work index (gm/m
2) . Myocardial
oxygen extraction (ml oxygen/ml) was calculated as arterial
oxygen content (ml
oxygen/ml) minus coronary venous oxygen
content (ml oxygen/ml), and myocardial oxygen consumption
(mi/min) was calculated as the product of myocardial oxygen
extraction (ml oxygen/m) and coronary blood flow (mllmin) .
Percent myocardial lactate extraction was calculated as 100 x
(arterial' lactate content (mmollliter] - coronary venous lactate
content [mmollliter])/arterial lactate content (mmol/liter)
. Myo-
cardial lactate, catecholamine and angiotensin II uptake (mmolf
min, nmollmin and pmol/min, respectively) were calculated by
multiplying the respective differences in arterial and coronary
venous levels with the instantaneous coronary sinus blood flow
(ml/min).
Study p . Patients were studied 45 to 60 min after
the last coronary angiogram and 25 to 30 min after instru-
mentation. Hence, all studies were performed between 10
:30
and 11 :30 AM, with the patient resting and supine for
approximately 2 h . First, multiple control measurements of
all hemodynamic variables were performed to ensure stable
baseline values. Next, duplicate arterial and coronary ve-
nous blood samples for metabolic and neurohumoral vari-
ables were collected . Then, an atrial pacing stress test
was carried out, during which heart rate was elevated by
10 beats/2 min until anginal pain or atrioventricular block
occurred, or a maximal heart rate of 170 beatstmin was
reached. The patient always determined which level of
anginal pain he or she would endure and, hence, the duration
of the atrial pacing stress test . However, pacing was typi-
cally continued until the level of angina was at least compa-
rable to that at which the patient would normally discontinue
exercise or take sublingual nitroglycerin .
During maximal heart rates, just before cessation of pacing,
all variables, including neurohormone levels, were reassessed,
followed by repeated measurements of all variables at 1, 2 and
30 min after pacing. The sequence of blood sampling after
pacing was such that exactly at 15 s after pacing, blood was
collected for lactate levels, followed immediately by the col-
lection of blood for neurohormone levels. This sequence was
repeated during the 2- and 30-min interval after pacing . Coro-
nary flow and cardiac output were not determined during the
first 2 min after pacing . In a limited number of patients,
neurohormones and lactate levels and hemodynamic variables
were also evaluated at 5 min after pacing .
During the interval between pacing and the 30-min eval-
uation, patients rested without further instrumentation or
investigational procedures . During the study, approximately
60 ml of blood was collected . Before each sample, catheters
were emptied to obviate the collection of residual saline solu-
tion and blood, which were returned to the patient after
sampling.
S
Rub*.
Data are presented as mean value ±
SEM. Thechange in values between measurements during and
after pacing and baseline were calculated . Group differences at
baseline and for calculated changes were examined using a
one-way analysis of variance . Within-group comparisons with
baseline values were evaluated using an analysis of variance for
repeated measurements, followed by a multiple comparison
test according to Dunnett. Comparisons between baseline
values and noncontinuous data assessed at 5 and 30 ruin after
pacing were carried out with a two-tailed paired t test . Coeffi-
cients of correlation were calculated where appropriate . A
p value < 0.05 was regarded as significant .
Results
On the basis of objective signs of myocardial ischemia
during pacing (e .g ., >0.1-mV ST segment depression), pa-
tients were classified in an ischemic (n = 45) or nonischemic
group (n = It) . Patients with ischemia were subsequently
classified into those with (n = 28) and without (n = 17)
lactate production. The reason for this subgrouping of pa-
tients with ischemia was twofold . First, it was hypothesized
that patients who produce lactate have more severe ischemia
than those who do not produce lactate . Hence, a correlation
between neurohormonal stimulation and degree of ischemia
might be made . Second, lactate production at least ensured
that (part of) the coronary venous effluent, collected during
the study, represented the ischemic area and might thus
allow identification of changes in neurohormonal release
from that area. Angina during pacing-induced stress was not
considered a true representation of myocardial ischemia
(17) . Anginalike symptoms occurred in 6 (55%), 14 (82%) and
23 (82%) patients in the nonischemic and lactate- and non-
lactate-producing groups, respectively .
Clinical and giographic characteristics of the three
groups (Table 1). Groups were comparable with regard to
gender, age, number of old infarcts, left ventricular volume
Table I. Baseline Clinical and Angiographic Data
JACC Vol, 23, No. I
Unless otherwise indicated, values presented are mean value ± SEM or
number of patients, ant = anterior ; F = female ; Inf = inferior, LP = lactate
producing ; UR = left/right ; LVEDV = left ventricular end-diastolic volume ;
LVEF = left ventricular ejection fraction ; M = male; MI = myocardial
infarction ; NI = nonischemic ; NLP = nonlactate producing .
Group
NI
(n = 11)
LP
(n = 28)
NLP
(n = 17)
M/F 9/2 2810 15/2
Age (y4) 49'-' 3J 55 t 1 .7 54 *- 2 .4
Range 31-66 37-73 36-71
Previous MI tant/inU 411 814 215
Positive exercise test result 20 10
Coronary angiography
(==70% diameter stenosis)
0 vessel 4 0 0
1 vessel (1JR) 311 7/I 4/I
2 vessels 1 12 6
3 vessels 2 9 5
LVEF (%n) 54 ± 3 .5 52±2.6 53±3 .1
LVEDV (MI/r2) 74 t 6 .7 69±4.8 67±3 .7
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Table 2. Systemic Hemodycamic Variables During avid After Pacing
and ejection fraction . In contrast, objective signs ofischemia
during exercise occurred more often in both groups with
ischemia than in the nonischemic group . Similarly, coronary
artery disease was less severe in the nonischemic group . The
two ischemic groups were similar with respect to the number
of vessels diseased . Although a >70% stenosis in a dominant
right coronary artery was the only significant lesion in one
patient in each group, each of these two patients had
additional 50% lesions in the left coronary artery .
Heat yna °c, metabolic and neurohumoral values at
baseline. At baseline, no patient had clinical signs or symp-
toms of myocardial ischemia . Although baseline values of
hemodynonuic variables were comparable in the three groups
(Tables 2 anti 3), coronary resistance was significantly higher
in lactate producers . In this group, baseline coronary venous
norepinephrine and epinephrine levels were also signifi-
cantly higher. Neurohormone levels otherwise did not differ
RYMME ET AL
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*p < 0.05 versus baseline. t p < 0 .05 versus other groups . ,*.p < 0.05 ®APST (change from baseline during maximal pacing) versus other QAPST
. Values
presented are mean value ± SEM. CO = cardiac output ; DP = double (rate-pressure) product ; dP/dt = first derivative of left ventricular pressure ; dP/dt neg (pos)
= peak negative (positive) dP/di ; HR = heart rate ; LVSP = left ventricular systolic pressure ; Tau,, Tau t = isovolumetric relaxation indexes ; Vmax =
dP/dtlpressure (P) extrapolated to P = 0 mm Hg total pressure
. Other abbreviations as in Table 1 .
in the three groups, except for arterial and coronary venous
dopamine values, which were lower in nonlactate producers .
Moreover, median values and range of individual arterial
epinephrine and norepinephrine levels were similar in the
three groups, as were individual arterial angiotensin II
values, although the latter varied widely, from <0 .2 to 24 .2
pmollliter.
Metabolic and ECG changes during and after pacing . By
design, only the lactate-producing group had abnormal myo-
cardial lactate metabolism (lactate extraction -76 ± 15%,
15 s after pacing, [mean ± SEMI) . ST segment changes,
however, were similar in both ischemic groups (-0 .21
0.03 and -0 .17 ± 0.02 mV in lactate and nonlactate produc-
ers, respectively) but were absent in the nonischemic group .
Coronary and systemic hentodynamic variables during and
after pacing. Changes in heart rate and the rate-pressure
product between baseline and maximal pacing were compa-
After Pacing
Baseline
Maximal
Pacing Rate
I min 5 rain
30 rain
LVSP (mm P9g)
LP 153 ¢ 5 .3 149 ± 6.0
162 ± 6 .6*f
153 ± 3 .3 144
t
7 .1
NLP
143 ± 6.5 139 ± 7.1 143 ± 6
.9 141 ± 7.3
137 ± 5.5
NI 138 ± 6 .6
130 ± 4 .Ot 136 ± 6
.5 134 ± 5 .2 135 ± 5
.5
DP (HR x LVSP x 10 -3)
LP
12±0.5
13±0.8 12±0
.5 9±0.6
22+0.9*
NLP 1 I ± 0 .7
20 ± 1 .2* 11±1
.0 11±0 .9
12±0.6
NI 10 ± 0.7
17± 1,2*t 10 ± 0 .7 10 ± 0.7
10 ± 0.5
dPtdt pos (mm Hg's - ')
LP
1,840 ± 117 1 .7% ± 65
1,686 ± 108
1,779 ± 80 2,241 ± 1264
NLP 1,715
± 102 2,363 ± 125* 1,740 ± 130
1,753 ± 103 1,720 ± 106
N 1 1,511 ± 134 1,897 *_ 138*
1,567 ± 124 1,547 ± 92
1,326 ± 69
Vmax (s`')
LP 56 2.7 11t 51±2 .9
49±2 .5
49±3 .3
50*2.6
NLP 50±2.4 68±3.5* 52±2.7
50±2.4 51±2.5
NI 45 ± 3 .5
59
± 3
.8* 44±3 .8
45±3 .6 41±2 .7
dP/dt neg (mm Hg's - ')
LP 1,914 ± 86 1 .971 ± 118 1,960 ± 103
1,980 ± 140 1,875 ± 136
NLP 1,883 ± 89 2,111 ± 115* 1,963 ± 125
1,858 ± 104 1,788 ± 74
N1 1,769 ± 127 1,999 ± 121* 1,776 ± 137 1,958 ± 147 1,852 ± 150
Tau, (ms)
LP 50 ± 45 47 ± 4.7r 51±4.9
51±4.8 50±7 .0
NLP 46 ± 1 .7 39 ± 2.2* 46±2 .3
48±2 .1 50± 1 .4
NI 53 ± 4 .7 43
± 3
.9° 52±4.9 56±7 .2 56*_5 .9
Tau
t
(ms)
LP 44 ± 4,7 55 ± 5.5*t 48±5 .1 44±5 .2
38±4 .0
NLP 37 ± 1 .2 39 . 3.1 38±2 .5 38±1.7 38±1 .5
NJ 42±3 .9 42±4.7 43±4 .1 41±4 .2 43±4 .2
CO (literlm)
LP 5.9 ± 0 .3 5.3±0.3* 6.0¢0.4
NLP 5.4 ± 0 .3
4
.9 ± 0.2 5 .7 ± 0 .5
NJ 5 .0 ± 0 .4
4
.8 ± 0.4
4
.7 ± 0 .5
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Table 3 . Coronary Hemodynamic Variables During and After Pacing
'p < 0.05 vs . baseline. t p < 0.05 vs. other groups. Values presented are mean value ± SEM . CSBF = coronary
sinus blood flow; CVR = coronary vascular resistance ; 6A-CSO, = myocardial oxygen extraction : MVO, _
myocardial oxygen consumption ; other abbreviations as in Table 1 .
rable in the three groups, although as a result of a more
profound reduction in left ventricular systolic pressure dur-
ing pacing in the nonischemic group, the absolute value for
rate-pressure product was significantly lower than in the
other groups (Table 2) . Also, changes in coronary hemody-
namic variables during pacing were similar in the three
patient groups (Table 3). In contrast, isovolumetric contrac-
tility and relaxation variables improved markedly in the
nonischemic and non-lactate-producing groups but did not
improve, or were significantly lower, in the lactate-
producing group (Table 2) . Moreover, taut lengthened in
lactate producers but not in the other groups . Also, left
ventricular end-diastolic pressure increased significantly
from 13 ± 1 .5 (baseline) to 24 ± 2.5 mm Hg at 10 s after
pacing. In contrast, in the other groups left ventricular
end-diastolic pressure decreased significantly during pacing
and returned to baseline levels immediately after pacing .
Furthermore, cardiac output decreased from 5 .9 ± 0.35
(baseline) to 5 .3 ± 0.37 liters/min (5 min after pacing, p <
0.05) in the lactate-producing group, accompanied by a
significant 23% increase in systemic vascular resistance (Fig.
1). No such changes were observed in the other groups .
Moreover, whereas arterial pressures increased in both
ischemic groups, these changes were more extensive and
longer lasting in lactate producers than in nonlactate produc-
ers.
Neurohumoral changes during and after pacing . Neither
arterial nor coronary venous neurohumoral levels changed
during or after pacing in the nonischemic group (Fig . 2),
whereas in the ischemic group dopamine levels remained
unaltered
. In contrast, arterial norepinephrine increased
significantly from 1 .91 ± 0 .18 (baseline) to 2.8 ± 0.26 nmollliter
(after pacing), with a further increase to 3 .21 ± 0.34 nmollliter
(I min after pacing) in lactate producers, accompanied by
significant, albeit less pronounced, increases in coronary ve-
nous norepinephrine levels. In nonlactate producers, these
changes were not as profound and consistent . However,
arterial norepinephrine increased by 36% in nonlactate ver-
sus 68% in lactate producers (p < 0.05). Elevated arterial
and coronary venous epinephrine levels were observed in
Figure 1 . Effect of pacing-induced ischemia on arterial pressures
and systemic vascular resistance (SVR) . In patients producing
lactate (LP) a marked increase is observed in mean arterial pressure
(MAP), starting at 120 beats/min (blmin) and persisting until 2 min
after pacing (p-p). In contrast, in nonlactate producers (NLP) a
moderate increase occurs at maximal pacing (MAX) only, whereas
arterial pressures do not change in patients in the nonischemic (NI)
group. Also, systemic resistance is still elevated at 5 min after
pacing in lactate producers but not in the other groups . Values are
mean value ± SEM . d = dynes.
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120 b I min MAX
I min p-p 2 min p-p 5 min p-p
Baseline
Maximal
Pacing Rate
5 min After
Pacing
30 min After
Pacing
CSBP (ml/min)
LP
117 ± 12 205 ± 19*
126 ± 14 112 ± 19
NLP 122 ± 6
175 *_ 24* 116 ± 9 110 ± 12
NJ
137 ±15 202 ± 32 149 ± 15
144 ± 25
CVR (mm Iiglml per m)
LP 1.19±0.121
0.73 ± 0.06* 1 .19 ± 0 .13 1.32±0 .14
NLP 0
.90±0.10 0.75±0.09 0.95 ± 0 .10
1
.01±0 .11
NI 0
.71±0.08 0.58 ± 0.13 0 .74 ± 0 .13 0.87 ± 0 .18
AA-CSO
2 (mllmin)
LP 12±0.5
12 ± 0.6 11 0 .6 11±0.6
NLP 12 ± 0.7
12 ± 0.7 12±0.7 13±0.8
NJ
1410.6 12 ± 0.9 13±0.8 13±0.9
MV02 (rnimin)
LP 12 ±
1 .1
22±2
.0* 12±1 .0 11±1 .5
NLP
14 ± 1 .6 21±2 .5' 13 ± 1 .3 15±2 .0
NJ
19 ± 2.8f 23±4 .9 20±2.7f 20±5 .5
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both ischemic groups during maximal pacing . Again,
changes were more profound in lactate producers . Arterial
angiotensin 11 levels also increased but only in lactate
producers, from 6.8 ± 0.9 (baseline) to 9 .7 ± 1 .6 pmol/liter
(I min after pacing, p < 0 .05) . Values were still significantly
elevated at 5 min after pacing . Coronary venous levels did
not change in either group .
Neurohumoral changes did not correlate with lactate
production values . However, a significant correlation was
observed between changes in arterial norepinephrine and left
ventricular end-diastolic pressure in the lactate-producing
group (p < 0.05) .
Cardiac neurohormonal balance during pacing and isch-
emia . Data for transcardiac neurohormone levels and coro-
nary flow were available in 19 lactate and 15 nonlactate
producers and 9 patients in the nonischemic group . Baseline
values for the transcardiac balance of catecholamines and
angiotensin II did not differ in the three groups (Fig . 3) .
During and after pacing, no changes were found in cardiac
dopamine balance. Similarly, myocardial fluxes of the other
catecholamines remained unaltered in the nonischemic
group. In contrast, in lactate producers, net myocardial
norepinephrine release, present at baseline, changed signif-
icantly to net uptake during maximal pacing rates (-0 .05 ±
0.02 vs. 0.06 ± 0 .05 nmollmin, respectively, (Fig . 3). No
such changes occurred in nonlactate producers . Cardiac
epinephrine uptake increased significantly in both ischemic
groups, although it was more pronounced in lactate produc-
ers. Ischemia-induced changes in catecholamine fluxes were
back to baseline values at 5 min after pacing (Fig . 3) . In the
REMME ET At_
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Figure 2 . Sequential changes in neurohormone levels during maxi-
mal pacing and for 30 min (') after pacing. At baseline, neurchor-
mone values are comparable, although coronary venous (open
circles) norepincphrine and epinephrine values in patients producing
lactate (LP) are significantly higher than in the other groups . During
pacing, no changes occur in patients in the nonischemic group (NT)-
In contrast, a significant increase in arterial (closed circles) and
coronary venous norepinephrine and epinephrine occurs in lactate
and nonlactate producers . Changes are more pronounced and sus-
tained in lactate producers . Also, arterial angiotensin 11 increases
significantly in lactate producers but not in nonlactate producers .
*p < 0 .05 vs . baseline ; tp < 0 .05 vs. other groups . Abbreviations as
in Figure 1 .
lactate-producing group, individual values for angiotensin 11
were variable at baseline, with uptake in the majority of
patients and release in seven (Fig . 4). Facing did not alter
this pattern significantly, although lactate producers tended
to have greater cardiac angiotensin II uptake during pacing-
induced ischemia. Changes in arterial angiotensin 11 levels
during pacing correlated significantly with simultaneous car-
diac uptake values (p < 0 .01) .
Heasodynamic, metabolic and neurohurnoral variables af-
ter a XnAn rest period . After 30 min of rest, all variables
had returned to baseline values in the three patient groups .
Discussion
The present study provides evidence that systemic cate-
cholamines are stimulated during short periods of st'Fess-
induced myocardial ischemia and that the level of activation
1'P-P 2'P-P
5'P-P 30'P-P
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CARDIAC NOREPINEPHRINE BALANCE
nmdUmn
0.1-
0.05-
0
.0
.05-
.0.1-
CARDIAC EPINEPHRINE UPTAKE
0,05-
0
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Figure 3. Sequential alterations in cardiac neurohumoral balance .
Changes in catecholamine balance in ischemic patients with and
without lactate production are present during maximal pacing rates
and return to baseline values at 5 min after pacing
. Values are mean
value ± SEM. *p < 0 .05 vs . baseline. Abbreviations as in Figure 1 .
depends on the degree of ischemia . Second, it shows that, in
humans, ischemia activates the circulating renin-angiotensin
system, again as a function of the severity of ischemia, and
that more severe ischemia and, hence, greater neurohor-
monal stimulation lead to a more profounc, increase in
systemic resistance and arterial pressures . Finally, it indi-
cates that acute, short-term ischemia results in a change
from net cardiac norepinephrine release to net uptake, but
only in patients who produce lactate, most likely reflecting
an alteration in the ischemic area . In contrast, epinephrine
uptake is enhanced in all patients with ischemia .
Ischemia-induced changes in systemic catecholani levels :
secondary to angina? In this study, arterial norepinephrine
and epinephrine levels increased significantly in both isch-
emic groups during pacing-induced ischemia . By contrast,
this did not occur in the nonischemic group despite equiva-
lent increments in heart rate and the presence of anginal
symptoms in the majority of these patients . The latter finding
does not support a role for angina in sympathetic activation
as a result of ischemia .
Previous investigations have focused on neurohormonal
changes during stress-induced angina . Because these studies
have not always stipulated the presence of objective signs of
ischemia (9,15,19) or included patients without myocardial
ischemia (20), it is difficult to dissociate the effect of stress
caused by angina from that of ischemia as such . Taken
together, in most studies in which pacing-induced stress was
applied, no significant changes in circulating norepinephrine
or epinephrine levels have been observed during angina
(8-10,21) . Only Emmanuelson et al. (18), in a study design
comparable to that of ours, reported a rise in circulating
catecholamine levels. Thus, other mechanisms than angina
may be responsible for the effect of ischemia on neurohor-
mone levels observed in our study .
receptor-induced sympathetic stimulation and severity
of isehemia. As hypothesized at the outset of the study,
patients who produced lactate had clearly more severe
ischemia, as illustrated by the abnormalities in contractility,
relaxation and left ventricular filling pressure in these pa-
tients compared with the nonlactate producers, despite
similar baseline characteristics and pacing conditions . More-
over, cardiac output was significantly reduced at 5 min after
pacing and probably more so during and immediately after
pacing
. A reduction in cardiac output during the develop-
ment of ischemia may reset arterial baroreceptors, stimulat-
ing the vasomotor center in the medulla oblongata . Whether
this results in a secondary overshoot or mainly helps to
amplify the stimulus for systemic vasoconstriction derived
from sympathetic afferent nerves is unknown . Also, it does
not explain why moderate, short-term neuroendocrine acti-
vation was observed in nonlactate producers who were in
the ischemic group but had myocardial muscle and cardiac
pump function that remained unimpaired during the test .
Is the cardiac sympathosympathetic reflex involved in
catecholamine activation during ischemia? An intriguing hy-
pothesis is that a cardiac sympathosympathetic reflex may
be involved in sympathetic activation during ischemia in the
absence of cardiac dysfunction (22,23) . Very little is known
of this reflex in humans . Although animal studies suggest
that ischemia needs to be transrnural (i .e ., relatively severe)
to induce a sympathetic reflex response (24), our observa-
tions in nonlactate producers would support a reflex that
initiates in the heart, secondary to local ischemic changes,
and leads to increased circulating catecholamines and a
subsequent increase in arterial tone, even in conditions of
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Figure 4. Individual changes in cardiac nor-
epinephrine balance and in epinephrine and
angiotensin II uptake by the heart in isch-
emic patients with myocardial lactate pro-
duction . During maximal pacing (MAX)
rates, norepinephrine release present at
baseline reverses to uptake . Also, epineph-
rine uptake increases significantly . In con-
trast, angiotensin U fluxes are too variable,
although there is a tendency toward en-
hanced uptake . *p < 0 .05 vs . baseline .
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mild ischemia . The mechanisms that initiate this reflex are
not clear from our data .
Mechanical stimuli or lactate may activate mechanore-
ceptors with afferent nerves to the tractus solitaries in the
medulla oblongata during anterior wall ischemia. Alterna-
tively, receptors with vagal C fiber afferents located in the
inferoposterior part of the heart depress the vasomotor
center after increments in preload . The (overall) hemody-
namic and metabolic profile during mild pacing-induced
ischemia in nonlactate producers does not favor a central
modulation of sympathetic tone through these mechanisms
in these patients. In contrast, in patients who produce lactate
and have more pronounced ischemia, these factors, together
with baroreceptor-dependent effects, may have contributed
to the profound neurohormonal stimulation and subsequent
systemic vasoconstriction observed in this group . Do they
also explain the increase in circulating angiotensin 11 levels?
Circulating anglotensin II levels and degree of myocardial
ischemia. Our data indicate that stimulation of the circulat-
ing renin-angiotensin system only occurs when ischemia is
severe enough to reduce cardiac and stroke output . Even
slight decreases in stroke volume are sensed by arterial
baroreceptors and may activate renal sympathetic nerves
(25) . Baroreftex activation of renal nerves stimulates renin
release, possibly through a direct beta-adrenergic influence
on juxtaglomerular cells (26) . Alternatively, the significant
REMME ET AL .
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increase in circulating catecholamines may increase the
threshold pressure for renin release (27) . Several animal
studies have indicated that components of the circulating
renin-angiotensin system change during ischemia (28,29) . A
significant elevation of arterial renin and angiotensin 11 levels
has been observed 30 s after coronary occlusion in the dog
(30) . Of importance, these changes do not occur in nephrec-
tornized animals. In contrast, pretreatment with propranolol
has no effect on ischemia-induced renin activation (30) .
Although beta-adrenergic receptor blockade does not effect
the change in threshold pressure for renin release induced by
reflex activation of renal sympathetic nerves (31), alpha-
adrenergic receptor blockade does (32) . In view of the
significant increase in circulating catecholamines in our
study, such a resetting may have influenced angiotensin 11
levels during ischemia despite the concomitant increase in
arterial pressure.
Cardiac neurobumoral balance at rest and during myocar-
dial ischemia. Although, during ischemia, a positive corre-
lation was present between changes in arterial levels of
angiotensin 11 and cardiac uptake, cardiac angiotensin 11
balance was not altered by ischemia . By contrast, ischemia
significantly changed net cardiac norepinephrine release,
present at baseline, to net uptake in patients with lactate
production . Because no such changes were found in patients
in the ischemic group without lactate production or in the
JACC Vol . 23, No. I
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nonischemic group, this suggests an alteration in norepi-
nepluine kinetics in the ischemic area .
Whether myocardial ischemia resulted in diminished re-
gional norepinephrine spillover or enhanced clearance can-
not be deduced from the present study . This determination
would necessitate tracer techniques with long equilibration
times under control conditions not well suited for invasive
investigations, in which the overall study duration is an
important restrictive factor (10,33,34). In animal experi-
ments, relatively long periods of severe myocardial ischemia
result in norepinephrine overflow (7) . which is generally
believed to reflect enhanced sympathetic activity secondary
to stress or enhanced autonomic reflexes (35) . However.
during short periods of ischemia, comparable to the model of
pacing-induced stress in humans, norepinephrine overflow is
either minor (7) or absent (36,37) . Thus far, patient studies in
which mild to moderate ischemia was induced over short
intervals were unable to show enhanced cardiac norepineph-
rine release (8-10) . The present study is the first to indicate
that during myocardial ischemia, not only is enhanced net
norepinephrine release absent, but also, in contrast, net
release observed at baseline may be reversed to net uptake
in the ischemic area . The underlying mechanisms for this
change in norepinephrine kinetics can only be hypothesized
in the absence of clearance measurements . A reduction in
efflux from the ischemic area as a result of diminished
venous outflow is unlikely in view of the increase in coro-
nary venous lactate levels . Enhanced neuronal reuptake of
norepinephrine during ischemia has been described, but only
in experiments that are unlikely to reflect our study condi-
tions (38). Local norepinephrine release from stimulated
cardiac sympathetic nerves (exocytotic release) depends on
neuronal high energy phosphate levels (39) and may de-
crease as a result of reduced availability of the latter during
ischemia. However, this process is time dependent and
probably cannot account for the early changes observed in
our studies . An alternative, attractive hypothesis is presyn-
aftic inhibition of exocytotic norepinephrine release by
adenosine (40), which accumulates in the ischemic area (41)
and is produced during pacing-induced ischemia in humans
(42,43).
In contrast to norepinephrine, epinephrine uptake was
enhanced ire all patients with ischemia irrespective of the
degree of ischemia. This finding suggests that epinephrine
uptake by the heart is not specific . Enhanced cardiac extrac-
tion of epinephrine has been described in association with
increased arterial epinephrine levels during relatively short
periods of ischcmia in a canine model (37) .
Neurohumoral stimulation and vasoconstriction . Our
study indicates that magnitude and duration of systemic
vasoconstriction depend on the degree of ischemia and
subsequent catecholamine activation, and, in severe isch-
emia, on stimulation of the circulating renin-angiotensin
system
. Consequently, arterial pressures and systolic wall
stress are elevated, particularly in severe ischemia, and
result in an increase in myocardial oxygen demand. A
vicious circle may then ensue, whereby neurohormonal
activation and systemic vasoconstriction lead to further
aggravation of the initial ischemic event .
Our study does not provide evidence that ischemia-
induced neuroendocrine stimulation affects coronary vaso-
tone . If anything, coronary vascular resistance decreased
more in lactate producers than in other groups . This obser-
vation may reflect metabolic vasodilation in ischemic areas,
or, alternatively, because the thermodilution method mea-
sures overall rather than regional flow, pronounced coronary
vasodilation in nonischemic areas. During progressive re-
ductions in coronary flow, cardiac sympathetic stimulation
may convert metabolic coronary vasodilation to alpha-
adrenergic vasoconstriction (44-46) . Also, sympathetic
stimulation may lead to constriction of stenotic coronary
segments without an apparent effect on overall coronary
flow (47) . Therefore, the possibility that a local decrease in
coronary flow did indeed occur during ischemia cannot be
excluded in the present study .
Clinical implications . In this study, systemic neuroendo-
crine activation was associated with a sustained increase in
systemic vascular resistance, at least in more severe isch-
emia. Because this increase may significantly influence the
severity of the ischemic attack that initially provoked this
neurohumoral response, the clinical usefulness of therapy
that may reduce myocardial ischemia through neurohumoral
modulation should be further evaluated . In accordance with
our model and the results of the present study, anti-ischemic
efficacy may be anticipated during periods of relatively
severe ischemia in the resting, supine patient (e .g., during
unstable angina) . Preliminary observations that enalaprilat
and perindoprilat reduce stress-induced ischemia at rest by
modulating neurohormonal activation (48,49) emphasize the
potential importance of converting enzyme inhibitors as
(additional) anti-ischemic therapy .
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